CSIMarket
 


Kewaunee Scientific Corporation  (KEQU)
Other Ticker:  
 

Cumulative Kewaunee Scientific's Leverage Ratio for Trailing Twelve Months Period

KEQU's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

KEQU Leverage Ratio for Trailing Twelve Months Period

(Apr 30 2024)
IV. Quarter
(Jan 31 2024)
III. Quarter
(Oct 31 2023)
II. Quarter
(Jul 31 2023)
I. Quarter
(Apr 30 2023)
IV. Quarter
Y / Y Equity Growth 46.05 % 24.78 % 24.01 % 15.23 % 6.37 %
Y / Y Total Liabilities Growth -1.82 % -4.87 % -6.04 % -6.12 % -1.91 %
Leverage Ratio for Trailing Twelve Months Period 1.76 1.96 2.1 2.25 2.37
Total Ranking # 1833 # 2285 # 2738 # 2965 # 3263
Seq. Equity Growth 23.97 % 4.44 % 7.09 % 5.34 % 5.91 %
Seq. Total Liabilities Growth -2.7 % 3.29 % -6.78 % 4.78 % -5.72 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Apr 30 2024
On the trailing twelve months basis Due to debt repayement of -2.7% Kewaunee Scientific decreased Leverage Ratio for Trailing Twelve Months Period in the IV. Quarter to 1.76, above Kewaunee Scientific's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Laboratory Analytical Instruments industry 13 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Kewaunee Scientific. While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are KEQU's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 14
Sector # 425
S&P 500 # 1632


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
2.4 1.17 0.69
(Jan 31 2023)   (Jan 31 2019)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Apr 30 2024, within Laboratory Analytical Instruments Industry Leverage Ratio for Trailing Twelve Months Period
Akoya Biosciences Inc   2.39 
Kewaunee Scientific Corporation  1.82 
Bruker Corporation  1.78 
Pacific Biosciences Of California Inc   1.67 
Codex Dna Inc   1.43 
Avantor Inc   1.41 
Eyepoint Pharmaceuticals Inc   1.35 
Harvard Bioscience Inc  0.92 
Agilent Technologies inc   0.84 
Phenomex Inc   0.78 
Revvity Inc  0.74 
Illumina Inc   0.55 
Bio rad Laboratories Inc   0.40 
Bionano Genomics Inc   0.36 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com